Background: Phase‐contrast (PC) MRI is a feasible and valid noninvasive technique to measure renal artery blood flow, showing potential to support diagnosis and monitoring of renal diseases. However, the variability in measured renal blood flow values across studies is large, most likely due to differences in PC‐MRI acquisition and processing. Standardized acquisition and processing protocols are therefore needed to minimize this variability and maximize the potential of renal PC‐MRI as a clinically useful tool.Purpose: To build technical recommendations for the acquisition, processing, and analysis of renal 2D PC‐MRI data in human subjects to promote standardization of renal blood flow measurements and facilitate the comparability of results across scanners and in multicenter clinical studies.Study Type: Systematic consensus process using a modified Delphi method.Population: Not applicable.Sequence Field/Strength: Renal fast gradient echo‐based 2D PC‐MRI.Assessment: An international panel of 27 experts from Europe, the USA, Australia, and Japan with 6 (interquartile range 4–10) years of experience in 2D PC‐MRI formulated consensus statements on renal 2D PC‐MRI in two rounds of surveys. Starting from a recently published systematic review article, literature‐based and data‐driven statements regarding patient preparation, hardware, acquisition protocol, analysis steps, and data reporting were formulated.Statistical Tests: Consensus was defined as ≥75% unanimity in response, and a clear preference was defined as 60–74% agreement among the experts.Results: Among 60 statements, 57 (95%) achieved consensus after the second‐round survey, while the remaining three showed a clear preference. Consensus statements resulted in specific recommendations for subject preparation, 2D renal PC‐MRI data acquisition, processing, and reporting.Data Conclusion: These recommendations might promote a widespread adoption of renal PC‐MRI, and may help foster the set‐up of multicenter studies aimed at defining reference values and building larger and more definitive evidence, and will facilitate clinical translation of PC‐MRI.Level of Evidence: 1Technical Efficacy Stage: 1
Satisfactory image quality and excellent negative predictive value were achieved at 1.5-T variable-refocusing-flip angle (FA) and constant-refocusing-FA fast spin-echo-based MR and flow-sensitive dephasing-prepared steady-state free precession MR for below-knee hemodynamically significant stenosis. PurposeTo evaluate diagnostic performance of three nonenhanced methods: variable-refocusing–flip angle (FA) fast spin-echo (SE)–based magnetic resonance (MR) angiography (variable FA MR) and constant-refocusing–FA fast SE–based MR angiography (constant-FA MR) and flow-sensitive dephasing (FSD)-prepared steady-state free precession MR angiography (FSD MR) for calf arteries, with dual-injection three-station contrast material–enhanced MR angiography (gadolinium-enhanced MR) as reference.Materials and MethodsThis prospective study was institutional review board approved and HIPAA compliant, with informed consent. Twenty-one patients (13 men, eight women; mean age, 62.6 years) underwent calf-station variable-FA MR, constant-FA MR, and FSD MR at 1.5 T, with gadolinium-enhanced MR as reference. Image quality and stenosis severity were assessed in 13 segments per leg by two radiologists blinded to clinical data. Combined constant-FA MR and FSD MR reading was also performed. Methods were compared (logistic regres...
OBJECTIVE. The purpose of this review is to illustrate various applications of gadofosveset trisodium in evaluating abdominal and peripheral vascular disease. The basic properties, technical considerations, and clinical and potential future applications of gadofosveset are described. CONCLUSION. Gadofosveset trisodium facilitates comprehensive high-resolution arterial and venous MR angiography. Because of its prolonged intravascular residence time, gadofosveset trisodium is particularly useful for evaluating venous, dynamic, and functional vascular disease with a single low-dose contrast injection.
Non–contrast-enhanced MR angiography is a powerful tool in evaluating the anatomy and physiology of vasculature, and the common sequences, underlying physics, benefits, and drawbacks of this techni... Unlike CT angiography, which requires the use of contrast medium, MR angiography (MRA) can be performed without the use of contrast agents. This subfield of MRA is referred to as non–contrast-enhan...